Division of Clinical Engineering, Tojinkai Hospital, Kyoto, Japan.
Faculty of Health Science, Morinomiya University of Medical Sciences, Osaka, Japan.
PLoS One. 2021 Dec 16;16(12):e0260671. doi: 10.1371/journal.pone.0260671. eCollection 2021.
The association between salt intake and clinical outcomes in hemodialysis patients has been controversial. This study aimed to clarify the association between salt intake and mortality in hemodialysis patients.
The present study included patients who underwent hemodialysis from June 1st 2016 to May 31st 2020. Corrected salt intake by ideal body weight was the main predictor of outcomes. Ideal body weight was calculated assuming that the ideal body mass index is 22 kg/m2 for the Japanese population. The multivariate Cox proportional hazards model was used to determine the association between corrected salt intake and mortality, adjusting for potential confounders. The outcomes considered were all-cause mortality and cumulative incidence of cardiovascular events at year 4.
A total of 492 adult patients were enrolled in the study. The mean daily salt intake and corrected salt intake at baseline were 9.5 g/day and 0.17 g/kg/day, respectively. The low corrected salt intake group (< 0.13 g/kg/day) demonstrated the highest 4-year all-cause mortality. No association was observed between corrected salt intake and the cumulative incidence of cardiovascular events. In multivariate Cox proportional hazards analysis, only the group with corrected salt intake of 0.16-0.20 g/kg/day was associated with a decreased hazard risk for all-cause death compared with the low corrected salt intake group.
The present study found that a low salt intake was associated with high all-cause mortality in hemodialysis patients. Reduced long-term survival may be attributed to malnutrition resulting from excessive salt restriction.
盐摄入量与血液透析患者临床结局之间的关联一直存在争议。本研究旨在阐明血液透析患者盐摄入量与死亡率之间的关系。
本研究纳入了 2016 年 6 月 1 日至 2020 年 5 月 31 日期间接受血液透析的患者。通过理想体重校正的盐摄入量是结局的主要预测指标。理想体重是基于日本人群理想体重指数为 22kg/m2 计算得出的。使用多变量 Cox 比例风险模型来确定校正盐摄入量与死亡率之间的关联,同时调整了潜在的混杂因素。考虑的结局包括全因死亡率和 4 年内心血管事件的累积发生率。
共有 492 名成年患者纳入本研究。基线时的平均每日盐摄入量和校正盐摄入量分别为 9.5g/天和 0.17g/kg/天。低校正盐摄入量组(<0.13g/kg/天)的 4 年全因死亡率最高。校正盐摄入量与心血管事件的累积发生率之间无关联。多变量 Cox 比例风险分析显示,仅校正盐摄入量为 0.16-0.20g/kg/天的组与低校正盐摄入量组相比,全因死亡的风险降低。
本研究发现,低盐摄入与血液透析患者的全因死亡率升高有关。长期生存率降低可能归因于过度盐限制导致的营养不良。